Literature DB >> 16888239

Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues.

Salman Choudhary1, Catherine L Higgins, Iou Yih Chen, Michael Reardon, Gerald Lawrie, G Wesley Vick, Christof Karmonik, David P Via, Joel D Morrisett.   

Abstract

BACKGROUND: Matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) play a central role in arterial wall remodeling, affecting stability of fibrous caps covering atherosclerotic plaques. The objective of this study was to determine the spatial distribution of TIMP mass and MMP mass and activity of carotid endarterectomy (CEA) tissues and relate it to the distribution of atherosclerotic lesions. METHODS AND
RESULTS: Fresh CEA tissues were imaged by multicontrast MRI to generate 3D reconstructions. Tissue segments were cut transversely from the common, bifurcation, internal, and external regions. Segments were subjected to total protein extractions and analyzed by ELISA for MMP-2 and -9 and TIMP-1 and -2 mass and by zymography for gelatinase activity. Segments at or near the bifurcation with highly calcified lesions contained higher MMP levels and activity than segments distant from the bifurcation; highly fibrotic or necrotic plaque contained lower MMP levels and activity and higher TIMP levels. Fatty streak, fibroatheroma with hemorrhage and calcification, and fully occluded lesions were enriched in MMP-2, MMP-9, and TIMP-1 and TIMP-2, respectively.
CONCLUSIONS: The spatial distribution of MMPs and TIMPs in carotid atherosclerotic lesions is highly heterogeneous, reflecting lesion location, size, and composition. This study provides the first semi-quantitative maps of differential distribution of MMPs and TIMPs over atherosclerotic plaques.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16888239     DOI: 10.1161/01.ATV.0000239461.87113.0b

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  29 in total

1.  Relationship between matrix metalloproteinase-9 and common carotid artery intima media thickness.

Authors:  Maged Abdelnaseer; Nervana Elfayomi; Eman H Esmail; Manal M Kamal; Ahmed Hamdy; Rasha M Abdel Samie; Enji Elsawy
Journal:  Neurol Sci       Date:  2015-08-30       Impact factor: 3.307

Review 2.  Imaging of atherosclerosis.

Authors:  D R J Owen; A C Lindsay; R P Choudhury; Z A Fayad
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

3.  Progress in atherosclerotic plaque imaging.

Authors:  Giulia Soloperto; Sergio Casciaro
Journal:  World J Radiol       Date:  2012-08-28

4.  Atherosclerosis plaque heterogeneity and response to therapy detected by in vivo molecular imaging of matrix metalloproteinase activation.

Authors:  Mahmoud Razavian; Sina Tavakoli; Jiasheng Zhang; Lei Nie; Lawrence W Dobrucki; Albert J Sinusas; Michael Azure; Simon Robinson; Mehran M Sadeghi
Journal:  J Nucl Med       Date:  2011-10-03       Impact factor: 10.057

5.  Multispectral optoacoustic tomography of matrix metalloproteinase activity in vulnerable human carotid plaques.

Authors:  Daniel Razansky; Niels J Harlaar; Jan Luuk Hillebrands; Adrian Taruttis; Eva Herzog; Clark J Zeebregts; Gooitzen M van Dam; Vasilis Ntziachristos
Journal:  Mol Imaging Biol       Date:  2012-06       Impact factor: 3.488

6.  Interleukin-6 release after carotid artery stenting and periprocedural new ischemic lesions.

Authors:  Yuko Abe; Manabu Sakaguchi; Shigetaka Furukado; Toshiyuki Fujinaka; Saburo Sakoda; Toshiki Yoshimine; Kazuo Kitagawa
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-02       Impact factor: 6.200

Review 7.  Radionuclide imaging: a molecular key to the atherosclerotic plaque.

Authors:  Harald F Langer; Roland Haubner; Bernd J Pichler; Meinrad Gawaz
Journal:  J Am Coll Cardiol       Date:  2008-07-01       Impact factor: 24.094

Review 8.  Metalloproteinases and vulnerable atherosclerotic plaques.

Authors:  Andrew C Newby
Journal:  Trends Cardiovasc Med       Date:  2007-11       Impact factor: 6.677

9.  Acrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophages.

Authors:  Timothy E O'Toole; Yu-Ting Zheng; Jason Hellmann; Daniel J Conklin; Oleg Barski; Aruni Bhatnagar
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-07       Impact factor: 4.219

Review 10.  Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke.

Authors:  Somnath Mukhopadhyay; David A Tulis
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.